BridgeMD
New treatment option for Fragility
Official title Impact of Nutritional Management on the Frailty of Patients Waiting for Liver Transplantation (Via the LFI Tool)
ClinicalTrials.gov ID: NCT06911619
What this study is testing
- What it's testing
- Cirrhosis is a major public health issue responsible for about 15000 deaths each year. Liver transplantation (LT) remains the only curative treatment for decompensated cirrhosis.
- Time commitment: about 24 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient aged ≥ 18 years
- Patient registered on the waiting list for Hepatic Transplantation in the Transplantation center of the Croix Rousse Hospital (GHN), Hospices Civils...
- Dated and signed an informed consent
- Affiliated to a social security scheme or beneficiary of a similar scheme
You likely can't join if
- Patient hospitalized in intensive care
- Patient with initial LFI test result \< to 3.2, that is considered as "robust".
- Patient unable to perform LFI exercises (chronic or acute motor disability in lower or upper limbs)
- Pregnant, parturient or lactating women
- Persons deprived of liberty by a judicial or administrative decision
- Persons under psychiatric care
See the full eligibility criteria
- Patient aged ≥ 18 years
- Patient registered on the waiting list for Hepatic Transplantation in the Transplantation center of the Croix Rousse Hospital (GHN), Hospices Civils de Lyon
- Dated and signed an informed consent
- Affiliated to a social security scheme or beneficiary of a similar scheme
- Patient hospitalized in intensive care
- Patient with initial LFI test result \< to 3.2, that is considered as "robust".
- Patient unable to perform LFI exercises (chronic or acute motor disability in lower or upper limbs)
- Pregnant, parturient or lactating women
- Persons deprived of liberty by a judicial or administrative decision
- Persons under psychiatric care
- Persons admitted to a health or social institution for purposes other than research
- Adults subject to a legal protection measure (guardianship, curatorship)
- Inability to understand protocol information
- Subject participating in another treatment research including an ongoing exclusion period at inclusion
The study team makes the final eligibility decision.
Where it's taking place
- Lyon, France
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 24 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.